About Pediococcus Acidilactici
Pediococcus Acidilactici is a Healthcare company based in Panchkula (India) founded in 2022. It manufactures enzymes and probiotics for biopharmaceutical, fine chemicals, food, feed, and cosmetics applications. It operates on a B2B model in Healthcare and Agriculture sectors. Its Indian entity Fido Pharma Private Limited reported revenue of ₹20.59 Cr. Pediococcus Acidilactici offers products and services including Pediococcus Acidilactici, Enzymes, Probiotics Blends, and Nutraceuticals. Its focus areas include Biopharmaceuticals, Probiotics, Manufacturing and Food and Agriculture Tech.
Company details
Fido Pharma Private Limited delivers enzyme solutions and probiotics for industries including biopharmaceutical, fine chemicals, food and feed, and cosmetics. They produce products like Pediococcus Acidilactici, a probiotic strain with antibacterial properties for gastrointestinal health. Based in India with facilities in Panchkula and Hyderabad, the company focuses on manufacturing high-quality formulations for industrial applications, serving clients in health and related sectors through direct supply chains.
- Headquarters Panchkula, India
- SectorsHealthcareAgriculture
- Email••••••••
- Phone•••• ••••
- Website pediococcusacidilactici.com
- Legal Name Fido Pharma Private Limited
- Date of Incorporation 04 Mar, 2020
- Jurisdiction Panchkula, Haryana, India
- Annual Revenue₹20.59 Cr
FY 2024 · +190% YoY
- Net Profit₹4.07 Cr
FY 2024 · 20% margin
- EBITDA₹4.89 Cr
FY 2024 · 24% margin
Associated legal entities of Pediococcus Acidilactici
Pediococcus Acidilactici operates through Fido Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Fido Pharma Private Limited CIN U24230HR2020PTC085725 | Active | 04 Mar 2020 | Panchkula, Haryana | ₹20.6 Cr | 3 | View details |
Products & Services of Pediococcus Acidilactici
Pediococcus Acidilactici offers a comprehensive portfolio of products and services, including Pediococcus Acidilactici, Enzymes, Probiotics Blends, and Nutraceuticals.
Probiotic strain offering antibacterial activity against pathogens in GI tract.
Solutions for industrial applications in health and food processing.
Blends for dietary supplements and health benefits.
Formulations supporting health in cosmetics and food industries.
Board of directors of Fido Pharma Private Limited (Pediococcus Acidilactici)
Fido Pharma Private Limited is the primary company behind Pediococcus Acidilactici. The board of Fido Pharma Private Limited currently have 3 directors; the longest-serving is Tejal Ashok Vispute, appointed in 2020. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tejal Ashok Vispute DIN 08717158 | Director | 04 Mar 2020 | 6 yrs 7 mo | Fido Pharma Private Limited |
| Parbhat Singh DIN 08717156 | Director | 04 Mar 2020 | 6 yrs 7 mo | Fido Pharma Private Limited |
| Ritu Raj Singh DIN 10186291 | Director | 30 May 2023 | 3 yrs 4 mo | Fido Pharma Private Limited |
Financials of Pediococcus Acidilactici
Figures of Fido Pharma Private Limited, the primary company behind Pediococcus Acidilactici, for FY 2024. Revenue was ₹20.59 Cr (+190% year on year). Net profit was ₹4.07 Cr (20% margin). EBITDA was ₹4.89 Cr (24% margin). Revenue has grown at a compounded annual rate of +114% over three years.
- ₹20.59 CrRevenue · FY 2024 · +190% YoY
- ₹4.07 CrNet profit · 20% margin
- ₹4.89 CrEBITDA · 24% margin
- ₹50 LakhPaid-up capital
- +114%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Fido Pharma Private Limited are on its company page.
Detailed financial statements for Pediococcus Acidilactici
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pediococcus Acidilactici
Pediococcus Acidilactici was founded in 2022.
Pediococcus Acidilactici is headquartered in Panchkula, India. It is registered at Panchkula, Haryana, India.
The primary company behind Pediococcus Acidilactici, Fido Pharma Private Limited, reported revenue of ₹20.59 Cr for FY 2024, up 190% year on year.
Fido Pharma Private Limited delivers enzyme solutions and probiotics for industries including biopharmaceutical, fine chemicals, food and feed, and cosmetics. They produce products like Pediococcus Acidilactici, a probiotic strain with antibacterial properties for gastrointestinal health. Based in India with facilities in Panchkula and Hyderabad, the company focuses on manufacturing high-quality formulations for industrial applications, serving clients in health and related sectors through direct supply chains.
Pediococcus Acidilactici offers Pediococcus Acidilactici, Enzymes, Probiotics Blends, and Nutraceuticals.
Pediococcus Acidilactici operates through Fido Pharma Private Limited.
The legal entities of Pediococcus Acidilactici currently have 3 directors, including Tejal Ashok Vispute, Parbhat Singh, Ritu Raj Singh.